NEUROFUSE Trademark

Trademark Overview

On Tuesday, August 25, 2020, a trademark application was filed for NEUROFUSE with the United States Patent and Trademark Office. The USPTO has given the NEUROFUSE trademark a serial number of 90135420. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by SynerFuse, Inc.. The NEUROFUSE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for use in treating chronic back pain
neurofuse

General Information

Serial Number90135420
Word MarkNEUROFUSE
Filing DateTuesday, August 25, 2020
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6755095
Registration DateTuesday, June 7, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2021

Trademark Statements

Pseudo MarkNEURO FUSE
Goods and ServicesMedical devices for use in treating chronic back pain

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, September 28, 2020
Primary Code010
First Use Anywhere DateThursday, January 13, 2022
First Use In Commerce DateThursday, January 13, 2022

Trademark Owner History

Party NameSynerFuse, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMinneapolis, MN 55416
Party NameSynerFuse, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMinneapolis, MN 55416
Party NameSynerFuse, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMinneapolis, MN 55416

Trademark Events

Event DateEvent Description
Friday, August 28, 2020NEW APPLICATION ENTERED
Monday, September 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 22, 2020ASSIGNED TO EXAMINER
Wednesday, January 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, January 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 20, 2021SOU TEAS EXTENSION RECEIVED
Monday, September 20, 2021SOU EXTENSION 1 FILED
Monday, September 20, 2021SOU EXTENSION 1 GRANTED
Thursday, March 10, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, September 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 10, 2022USE AMENDMENT FILED
Thursday, April 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 6, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 4, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 5, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Monday, August 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

neurofuse back pain chronic treating devices medical